10mgCOA image placeholder
VP-RT10
Triple-receptor agonist (GLP-1, GIP, glucagon) researched for metabolic regulation and body composition in preclinical models.
Studied for effects on appetite signalling, gastric emptying, insulin dynamics and energy expenditure. Phase 3 trials underway (TRIUMPH programme). Most searched next-generation weight management research compound in Australia.
Standalone or with Tesamorelin for visceral fat research
For research and laboratory purposes only. Not for human use. These statements have not been evaluated by the Therapeutic Goods Administration (TGA). This product is not intended to diagnose, treat, cure, or prevent any disease.